Novel CAR-T platform uses radiation-activated switch to destroy tumors more effectively

Medical Xpress - latest medical and health news stories ·
Health & Medicine United Kingdom

Engineering patients' own immune cells to find and destroy cancer using chimeric antigen receptor (CAR) T-cell therapy has transformed the treatment of blood cancers. However, its use is limited in solid tumors because the immunosuppressive tumor microenvironment prevents CAR T-cell entry into the tumor and causes cells that enter to become exhausted.

Read original article on Medical Xpress - latest medical and health news stories →